カテゴリー： QYResearch, 世界

選択的セロトニン再取り込み阻害薬（SSRI）の世界市場：規模・現状・予測

QYResearchが発行した調査報告書（DATA909X18951）
◆英語タイトル：Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18951
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：99
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
※当調査レポートでは、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場について調査・分析し、選択的セロトニン再取り込み阻害薬（SSRI）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（シタロプラム（セレキサ）、エシタロプラム（レキサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシル、ペクセバ）、セルトラリン（ゾロフト）、ビラゾドン（ビブリド））、用途別（うつ病、不安およびパニック障害、その他の精神状態）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の選択的セロトニン再取り込み阻害薬（SSRI）市場動向
・主要企業別マーケットシェア
・選択的セロトニン再取り込み阻害薬（SSRI）の種類別市場規模2014-2019
（シタロプラム（セレキサ）、エシタロプラム（レキサプロ）、フルオキセチン（プロザック）、パロキセチン（パキシル、ペクセバ）、セルトラリン（ゾロフト）、ビラゾドン（ビブリド））
・選択的セロトニン再取り込み阻害薬（SSRI）の用途別市場規模2014-2019
（うつ病、不安およびパニック障害、その他の精神状態）
・選択的セロトニン再取り込み阻害薬（SSRI）の北米市場：主要企業・種類別/用途別市場規模
・選択的セロトニン再取り込み阻害薬（SSRI）のヨーロッパ市場：主要企業・種類別/用途別市場規模
・選択的セロトニン再取り込み阻害薬（SSRI）の中国市場：主要企業・種類別/用途別市場規模
・選択的セロトニン再取り込み阻害薬（SSRI）の日本国内市場：主要企業・種類別/用途別市場規模
・選択的セロトニン再取り込み阻害薬（SSRI）の東南アジア市場：主要企業・種類別/用途別市場規模
・選択的セロトニン再取り込み阻害薬（SSRI）のインド市場：主要企業・種類別/用途別市場規模
・選択的セロトニン再取り込み阻害薬（SSRI）の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Allergan Plc、Eli Lilly and Co.、GlaxoSmithKline Plc、H. Lundbeck AS、Pfizer Inc.）
・選択的セロトニン再取り込み阻害薬（SSRI）の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They can ease symptoms of moderate to severe depression, are relatively safe and typically cause fewer side effects than other types of antidepressants do.With an increase in mental illnesses, there is a rising need for effective neurological drugs. Among the various neurological drugs available in the market, SSRIs drugs have high therapeutic efficacy. As a result, the number of vendors manufacturing these drugs is increasing. Moreover, health insurance companies, with support from governments, have started covering treatment expenses related to mental disorder. The rising prevalence of mental illnesses will significantly contribute to the selective serotonin reuptake inhibitors market growth.
In 2018, the global Selective Serotonin Reuptake Inhibitors (SSRIs) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Selective Serotonin Reuptake Inhibitors (SSRIs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Selective Serotonin Reuptake Inhibitors (SSRIs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Allergan Plc
Eli Lilly and Co.
GlaxoSmithKline Plc
H. Lundbeck AS
Pfizer Inc.
…

Market segment by Type, the product can be split into
Citalopram (Celexa)
Escitalopram (Lexapro)
Fluoxetine (Prozac)
Paroxetine (Paxil, Pexeva)
Sertraline (Zoloft)
Vilazodone (Viibryd)

Market segment by Application, split into
Depression
Anxiety and panic disorder
Other mental conditions

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Selective Serotonin Reuptake Inhibitors (SSRIs) status, future forecast, growth opportunity, key market and key players.
To present the Selective Serotonin Reuptake Inhibitors (SSRIs) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Selective Serotonin Reuptake Inhibitors (SSRIs) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Type (2014-2025)
1.4.2 Citalopram (Celexa)
1.4.3 Escitalopram (Lexapro)
1.4.4 Fluoxetine (Prozac)
1.4.5 Paroxetine (Paxil, Pexeva)
1.4.6 Sertraline (Zoloft)
1.4.7 Vilazodone (Viibryd)
1.5 Market by Application
1.5.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application (2019-2025)
1.5.2 Depression
1.5.3 Anxiety and panic disorder
1.5.4 Other mental conditions
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size
2.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Growth Trends by Regions
2.2.1 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Regions (2019-2025)
2.2.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by by Players
3.1.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue by by Players (2014-2019)
3.1.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by by Players (2014-2019)
3.1.3 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Concentration Ratio (CR5 and HHI)
3.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players Head office and Area Served
3.3 Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Product/Solution/Service
3.4 Date of Enter into Selective Serotonin Reuptake Inhibitors (SSRIs) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2014-2019)
4.2 Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2014-2019)

5 North America
5.1 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2014-2019)
5.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players in North America
5.3 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
5.4 North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application

6 Europe
6.1 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2014-2019)
6.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players in Europe
6.3 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
6.4 Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application

7 China
7.1 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2014-2019)
7.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players in China
7.3 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
7.4 China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application

8 Japan
8.1 Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2014-2019)
8.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players in Japan
8.3 Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
8.4 Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2014-2019)
9.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players in Southeast Asia
9.3 Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
9.4 Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application

10 India
10.1 India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2014-2019)
10.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players in India
10.3 India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
10.4 India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application

11 Central & South America
11.1 Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size (2014-2019)
11.2 Selective Serotonin Reuptake Inhibitors (SSRIs) Key Players in Central & South America
11.3 Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type
11.4 Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application

12 International Players Profiles
12.1 Allergan Plc
12.1.1 Allergan Plc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
12.1.4 Allergan Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019))
12.1.5 Allergan Plc Recent Development
12.2 Eli Lilly and Co.
12.2.1 Eli Lilly and Co. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
12.2.4 Eli Lilly and Co. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
12.2.5 Eli Lilly and Co. Recent Development
12.3 GlaxoSmithKline Plc
12.3.1 GlaxoSmithKline Plc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
12.3.4 GlaxoSmithKline Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
12.3.5 GlaxoSmithKline Plc Recent Development
12.4 H. Lundbeck AS
12.4.1 H. Lundbeck AS Company Details
12.4.2 Company Description and Business Overview
12.4.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
12.4.4 H. Lundbeck AS Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
12.4.5 H. Lundbeck AS Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Selective Serotonin Reuptake Inhibitors (SSRIs) Introduction
12.5.4 Pfizer Inc. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
12.5.5 Pfizer Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Selective Serotonin Reuptake Inhibitors (SSRIs) Key Market Segments
Table Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Covered
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Citalopram (Celexa) Figures
Table Key Players of Citalopram (Celexa)
Figuer Escitalopram (Lexapro) Figures
Table Key Players of Escitalopram (Lexapro)
Figuer Fluoxetine (Prozac) Figures
Table Key Players of Fluoxetine (Prozac)
Figuer Paroxetine (Paxil, Pexeva) Figures
Table Key Players of Paroxetine (Paxil, Pexeva)
Figuer Sertraline (Zoloft) Figures
Table Key Players of Sertraline (Zoloft)
Figuer Vilazodone (Viibryd) Figures
Table Key Players of Vilazodone (Viibryd)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application in 2018 & 2025
Figure Depression Case Studies
Figure Anxiety and panic disorder Case Studies
Figure Other mental conditions Case Studies
Figure Selective Serotonin Reuptake Inhibitors (SSRIs) Report Years Considered
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Regions 2019-2025 (Million US$)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Regions 2019-2025 (Million US$)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Regions 2014-2019
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Regions 2014-2019
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue by by Players (2014-2019) (Million US$)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by by Players (2014-2019)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by by Players in 2018
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Product/Solution/Service
Table Date of Enter into Selective Serotonin Reuptake Inhibitors (SSRIs) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type (2014-2019) (Million US$)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Share by Type (2014-2019)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Market Share by Type (2014-2019)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2014-2019) (Million US$)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Share by Application (2014-2019)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Market Share by Application (2014-2019)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue Market Share by Application in 2018
Figure North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size 2014-2019 (Million US$)
Table North America Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (2018-2019) (Million US$)
Table North America Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share (2018-2019)
Table North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type 2014-2019 (Million US$)
Table North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type 2014-2019
Table North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application 2014-2019 (Million US$)
Table North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application 2014-2019
Figure Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size 2014-2019 (Million US$)
Table Europe Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (2018-2019) (Million US$)
Table Europe Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share (2018-2019)
Table Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type 2014-2019 (Million US$)
Table Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type 2014-2019
Table Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application 2014-2019 (Million US$)
Table Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application 2014-2019
Figure China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size 2014-2019 (Million US$)
Table China Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (2018-2019) (Million US$)
Table China Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share (2018-2019)
Table China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type 2014-2019 (Million US$)
Table China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type 2014-2019
Table China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application 2014-2019 (Million US$)
Table China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application 2014-2019
Figure Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size 2014-2019 (Million US$)
Table Japan Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (2018-2019) (Million US$)
Table Japan Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share (2018-2019)
Table Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type 2014-2019 (Million US$)
Table Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type 2014-2019
Table Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application 2014-2019 (Million US$)
Table Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application 2014-2019
Figure Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share (2018-2019)
Table Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type 2014-2019
Table Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application 2014-2019
Figure India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size 2014-2019 (Million US$)
Table India Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (2018-2019) (Million US$)
Table India Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share (2018-2019)
Table India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type 2014-2019 (Million US$)
Table India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type 2014-2019
Table India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application 2014-2019 (Million US$)
Table India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application 2014-2019
Figure Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share (2018-2019)
Table Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Type 2014-2019 (Million US$)
Table Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Type 2014-2019
Table Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application 2014-2019 (Million US$)
Table Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Share by Application 2014-2019
Table Allergan Plc Company Details
Table Allergan Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business 2014-2019 (Million US$)
Figure Allergan Plc Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
Table Allergan Plc Recent Development
Table Eli Lilly and Co. Company Details
Table Eli Lilly and Co. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business 2014-2019 (Million US$)
Figure Eli Lilly and Co. Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
Table Eli Lilly and Co. Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Plc Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
Table GlaxoSmithKline Plc Recent Development
Table H. Lundbeck AS Company Details
Table H. Lundbeck AS Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business 2014-2019 (Million US$)
Figure H. Lundbeck AS Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
Table H. Lundbeck AS Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Selective Serotonin Reuptake Inhibitors (SSRIs) Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Selective Serotonin Reuptake Inhibitors (SSRIs) Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Regions (Million US$) 2019-2025
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Share by Regions (2019-2025)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Share by Regions in 2025
Figure North America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Forecast (2019-2025)(Million USD)
Figure China Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Forecast (2019-2025)(Million USD)
Figure India Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size Forecast (2019-2025)(Million USD)
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Product (2019-2025) (Million US$)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Product (2019-2025)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Product in 2025
Table Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2019-2025) (Million US$)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application (2019-2025)
Figure Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Allergan Plc、Eli Lilly and Co.、GlaxoSmithKline Plc、H. Lundbeck AS、Pfizer Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 選択的セロトニン再取り込み阻害薬（SSRI）の世界市場：規模・現状・予測(Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 高密度焦点式超音波（HIFU）治療の世界市場：規模・現状・予測
  • 世界の機械加工ミストコレクター産業：成長傾向・競合分析
  • 世界のリチウムイオンエネルギー蓄電池産業：成長傾向・競合分析
  • 世界の聴衆反応キーパッド産業：成長傾向・競合分析
  • 世界のトラクショントランス市場
  • 世界の信号灯市場
  • 世界のポータブルヒーター市場
  • 世界のナノファイバー市場
  • 世界のN,N,N’-トリメチルアミノエチルエタノールアミン（TMAEEA）市場
  • 世界のイソプロテレノール市場
  • 世界の道路標示用ガラスビーズ市場
  • 世界のドーザー機械制御システム市場
  • 世界の炭素繊維布市場
  • 世界のアルミ鋳造製品市場
  • 世界のオールマウンテンスキー市場